The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 77 results:
Author [ Title(Desc)] Type Year
Filters: Author is Doulberis, Michael  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Vardaka E., Touloumtzi M., et al. (2022).  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.. Arq Bras Cardiol. 119(3), 502-504.
Kountouras, J., Doulberis M., Polyzos S. A., Katsinelos T., Vardaka E., Kountouras C., et al. (2019).  Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia.. Alzheimers Dement. 15(5), 723-725.
Doulberis, M., Kountouras J., Polyzos S. A., Tzivras D., Vardaka E., Kountouras C., et al. (2018).  Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence.. Helicobacter. 23(6), e12534.
Kountouras, J., Doulberis M., Papaefthymiou A., & Polyzos S. A. (2020).  Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation risk.. Liver Int.
Kountouras, J., Papaefthymiou A., Doulberis M., Polyzos S. A., Zavos C., Kazakos E., et al. (2021).  Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction.. J Neurogastroenterol Motil. 27(1), 147-148.
Papaefthymiou, A., Doulberis M., Katsinelos P., Liatsos C., Polyzos S. A., Kotronis G., et al. (2019).  Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori-related nitrosative stress.. Ann N Y Acad Sci.
Ntona, S., Papaefthymiou A., Kountouras J., Gialamprinou D., Kotronis G., Boziki M., et al. (2023).  Impact of nonalcoholic fatty liver disease-related metabolic state on depression.. Neurochem Int. 163, 105484.
Papaefthymiou, A., Doulberis M., Kountouras J., Kolokytha C., Galanopoulos M., Liatsos C., et al. (2019).  Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey.. Eur J Gastroenterol Hepatol.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Deretzi G., Vardaka E., Soteriades E. S., et al. (2021).  Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension.. Microorganisms. 9(11), 
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Boziki M., Kyriakopoulos A., et al. (2021).  Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.. J Neurogastroenterol Motil. 27(4), 653-654.
Katsinelos, P., Lazaraki G., Anastasiadis S., Chatzimavroudis G., Katsinelos T., Terzoudis S., et al. (2019).  The impact of selective serotonin receptor inhibitors on post-endoscopic sphincterotomy bleeding, alone or with concurrent aspirin or nonsteroidal anti-inflammatory drugs.. Ann Gastroenterol. 32(6), 614-619.
Polyzos, S. A., Zeglinas C., Artemaki F., Doulberis M., Kazakos E., Katsinelos P., et al. (2018).   infection and esophageal adenocarcinoma: a review and a personal view.. Ann Gastroenterol. 31(1), 8-13.
Papaefthymiou, A., Potamianos S., Goulas A., Doulberis M., Kountouras J., & Polyzos S. A. (2021).  Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.. J Crohns Colitis.
Kountouras, J., Papaefthymiou A., Doulberis M., & Polyzos S. A. (2019).  Influence of Helicobacter pylori-connected metabolic syndrome on non-alcoholic fatty liver disease and its related colorectal neoplasm high risk.. Liver Int.
Kountouras, J., Kazakos E., Kyrailidi F., Polyzos S. A., Zavos C., Arapoglou S., et al. (2023).  Innate immunity and nonalcoholic fatty liver disease.. Ann Gastroenterol. 36(3), 244-256.
L
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., Liatsos C., Koffas A., et al. (2020).  Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease.. Aliment Pharmacol Ther. 51(2), 313-314.
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., & Kountouras J. (2020).  Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma.. Aliment Pharmacol Ther. 51(11), 1215-1216.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Touloumtzi M., et al. (2023).  Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.. Aliment Pharmacol Ther. 57(10), 1186-1187.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Vardaka E., Touloumtzi M., et al. (2022).  Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al.. Obes Surg. 32(6), 2079-2080.
M
Kountouras, J., Doulberis M., Polyzos S. A., & Katsinelos P. (2019).  Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease.. Ann Gastroenterol. 32(2), 214.
Katsinelos, T., Doulberis M., Polyzos S. A., Papaefthymiou A., Katsinelos P., & Kountouras J. (2019).  Molecular links between Alzheimer's disease and Gastrointestinal microbiota with its-related metabolic syndrome: emphasis on Helicobacter pylori infection involvement.. Curr Mol Med.
N
Papaefthymiou, A., Doulberis M., Polyzos S. A., & Kountouras J. (2020).  National consensus on infection: the next-day challenge.. Ann Gastroenterol. 33(3), 324-325.
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Makras P., Hawa G., Sonnleitner L., et al. (2018).  Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.. Hormones (Athens). 17(4), 573-579.
Polyzos, S. A., Kountouras J., Anastasiadis S., Doulberis M., & Katsinelos P. (2018).  Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?. Hepatology. 68(1), 389.
Polyzos, S. A., Papaefthymiou A., Doulberis M., & Kountouras J. (2023).  Nonalcoholic fatty liver disease test: an external validation cohort.. Hormones (Athens).

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.